Fri, Aug 29, 2014, 8:33 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

  • cobbob46 cobbob46 Oct 22, 2012 12:54 PM Flag

    Check out IPXL, Generic at $25 with proprietary Parkinsons drug to be approved in Jan. Maybe PFE should buy them?

    If you are seeking an opportunity I would reccomend Impax pharma IPXL at $25. They have Rytary a phase 3 drug for Parkinsons that should get approval in mid January. They have a pact with Glaxo for the Intl marketing of the drug and Glaxo will pay IPXL $175 mil upon approval. This will be a lead drug for Parkinsons with the least side affects.

    IPXL has $355 Mil in cash, no debt and should have a robust earnings report. They are an authorized generic with Astra Z for a big rev generating drug that will be highly profitable.

    Bottom line one of the few independent generics at a reasonable price with strong proprietary drugs. One will be approved in Jan and another by mid 2013 with good prospects.

    Check it out, I think it will rise to the $40's quickly barring a buyout by Teva or a large pharma that wants the Parkinsons market.

    PFE management should look into this one quickly!

    Sentiment: Strong Buy

 
PFE
29.39+0.01(+0.03%)Aug 29 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.